Lab Information
Giada Sebastiani (MD)
ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Keywords
Fatty liver • serum fibrosis biomarkers • hepatitis B • hepatitis C • HIVResearch Interests
My research focuses on screening for liver disease and fatty liver of at risk populations, including HIV+ patients, patients with inflammatory bowel disease, liver transplant recipients. To conduct these studies, I employ a non-invasive machine, which is ultrasound based, named Fibroscan. Moreover, I am conducting interventional trials to reduce the fatty liver by vitamin E and switch to less hepatotoxic drugs.Team Members
Name | Position |
---|
Latest Publications
- Pan, Z., Al-Busafi, S. A., Abdulla, M., Fouad, Y., Sebastiani, G. & Eslam, M. (2024). MAFLD identifies patients with significant hepatic fibrosis better than MASLD. Hepatology international.
- Zhang, L., El-Shabrawi, M., Baur, L. A., Byrne, C. D., Targher, G., Kehar, M., Porta, G., Lee, W. S., Lefere, S., Turan, S., Alisi, A., Weiss, R., Faienza, M. F., Ashraf, A., Sundaram, S. S., Srivastava, A., De Bruyne, R., Kang, Y., Bacopoulou, F., Zhou, Y.-H., Darma, A., Lupsor-Platon, M., Hamaguchi, M., Misra, A., Méndez-Sánchez, N., Ng, N. B. H., Marcus, C., Staiano, A. E., Waheed, N., Alqahtani, S. A., Giannini, C., Ocama, P., Nguyen, M. H., Arias-Loste, M. T., Ahmed, M. R., Sebastiani, G., Poovorawan, Y., Al Mahtab, M., Pericàs, J. M., Reverbel da Silveira, T., Hegyi, P., Azaz, A., Isa, H. M., Lertudomphonwanit, C., Farrag, M. I., Nugud, A. A. A., Du, H.-W., Qi, K.-M., Mouane, N., Cheng, X.-R., Al Lawati, T., Fagundes, E. D. T., Ghazinyan, H., Hadjipanayis, A., Fan, J.-G., Gimiga, N., Kamal, N. M., Ștefănescu, G., Hong, L., Diaconescu, S., Li, M., George, J. & Zheng, M.-H. (2024). An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease. Med (New York, N.Y.).
- Guaraldi, G., Milic, J., Renzetti, S., Motta, F., Cinque, F., Bischoff, J., Desilani, A., Conti, J., Medioli, F., Del Monte, M., Kablawi, D., Elgretli, W., Calza, S., Mussini, C., Rockstroh, J. K. & Sebastiani, G. (2024). The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV. AIDS (London, England).
- Douros, A., Cui, Y., Platt, R. W., Filion, K. B., Sebastiani, G. & Renoux, C. (2024). Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study. Thrombosis research, vol. 237, p. 71-78.
- Raggi, P., Milic, J., Manicardi, M., Cinque, F., Swain, M. G., Sebastiani, G. & Guaraldi, G. (2024). Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology. Atherosclerosis, vol. 392, p. 117523.
- Benmassaoud, A., Martel, M., Carli, F., Geraci, O., Daskalopoulou, S. S., Sebastiani, G. & Bessissow, A. (2024). Prehabilitation in patients awaiting liver transplantation. Transplantation reviews (Orlando, Fla.), vol. 38, p. 100835.
- Arora, A. K., Vicente, S., Engler, K., Lessard, D., Huerta, E., Ishak, J., Routy, J.-P., Klein, M., Kronfli, N., Cox, J., Lemire, B., de Pokomandy, A., Del Balso, L., Sebastiani, G., Vedel, I., Quesnel-Vallée, A., ASAP Migrant Advisory Committee & Lebouché, B. (2024). Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite B/F/TAF: 'The ASAP study'. HIV medicine.
- Burnside, J., Thomas, T., Sebastiani, G. & Saeed, S. (2023). Geographical disparities in gastroenterologists and transient elastography across Canada. Canadian liver journal, vol. 6, p. 417-424.
- Zoughlami, A., Serero, J., Congly, S., Zhao, I., Zhu, J., Ramji, A., Cooper, C., Wong, P., Bailey, R., Coffin, C. S., Sebastiani, G. & Canadian HBV Network (2023). Diagnosis of esophageal varices by liver stiffness and serum biomarkers in virus-related compensated advanced chronic liver disease. Canadian liver journal, vol. 6, p. 332-346.
- Feng, G., Valenti, L., Wong, V.-W., Fouad, Y. M., Yilmaz, Y., Kim, W., Sebastiani, G., Younossi, Z. M., Hernandez-Gea, V. & Zheng, M.-H. (2024). Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nature reviews. Gastroenterology & hepatology, vol. 21, p. 46-56.